MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

Breast Cancer Research

Volumn 16, Issue 1, 2014, Pages

  Li, Pei ^a   Sheng, Cheng ^a   Huang, Lingling ^a   Zhang, Hui ^b   Huang, Lihua ^b   Cheng, Zeneng ^a   Zhu, Qubo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; MICRORNA; MICRORNA 182; MICRORNA 183; MICRORNA 96; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN182 MICRORNA, HUMAN; MIRN183 MICRORNA, HUMAN; MIRN96 MICRORNA, HUMAN;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE CLUSTER; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LENTIVIRINAE; LUCIFERASE ASSAY; MICROSCOPY; NORTHERN BLOTTING; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION STUDY; WOUND HEALING; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; LUNG CARCINOMA; MCF 7 CELL LINE; PAGET NIPPLE DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; LENTIVIRUS; MCF-7 CELLS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84988878391     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0473-z     Document Type: Article

References (45)

1. Xu S, Witmer PD, Lumayag S, Kovacs B, Valle D: MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem 2007, 282:25053-25066
2. Xu D, He X, Chang Y, Xu C, Jiang X, Sun S, Lin J: Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. Oncol Rep 2013, 29:653-661
3. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, Giangreco AA, Martens-Uzunova E, Baqasra O, Kajdacsy-Balla A, Nonn L: miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem 2011, 286:44503-44511
4. Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, Senqupta S, Archer T, Remke M, Bai AH, Warren P, Pfister SM, Steen JA, Pomeroy SJ, Cho YJ: Pleiotropic effects of miR-183 ~ 96 ~ 182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol 2012, 123:539-552
5. Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu C, Li J, Wang X, Song L: Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 2010, 5:e15797
6. Guttilla IK, White BA: Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009, 284:23204-23216
7. Song L, Liu L, Wu Z, Li Y, Ying Z, Lin C, Wu J, Hu B, Cheng SY, Li M, Li J: TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets. J Clin Invest 2012, 122:3563-3578
8. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Boqunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E: Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 2009, 106:1814-1819
9. Sarver AL, Li L, Subramanian S: MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 2010, 70:9570-9580
10. Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, Qin Y, Sun Z, Zheng X: miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010, 10:354
11. Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W, Liu J, Yu J, Chen J: miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 2010, 70:6015-6025
12. Lowery AJ, Miller N, Dwyer RM, Kerin MJ: Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 2010, 10:502
13. Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X, Wang L: Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol 2012, 180:2440-2451
14. Sun Y, Fang R, Li C, Li L, Li F, Ye X, Chen H: Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 2010, 396:501-507
15. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN: MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060
16. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE: Chromatin structure analyses identify miRNA promoters. Genes Dev 2008, 22:3172-3183
17. Saini HK, Griffiths-Jones S, Enright AJ: Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci U S A 2007, 104:17719-17724
18. Wang G, Wang Y, Shen C, Huang YW, Huang K, Huang TH, Nephew KP, Li L, Liu Y: RNA polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation. PLoS One 2010, 5:e13798
19. Chien CH, Sun YM, Chang WC, Chiang-Hsieh PY, Lee TY, Tsai WC, Horng JT, Tsou AP, Huang HD: Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res 2011, 39:9345-9356
20. Ebert MS, Neilson JR, Sharp PA: MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007, 4:721-726
21. Zhu Q, Sun W, Okano K, Chen Y, Zhang N, Maeda T, Palczewski K: Sponge transgenic mouse model reveals important roles for the microRNA-183 (miR-183)/96/182 cluster in postmitotic photoreceptors of the retina. J Biol Chem 2011, 286:31749-31760
22. Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC: Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res 2013, 15:R76
23. Riaz M, van Jaarsveld MT, Hollestelle A, Prager-van der Smissen WJ, Heine AA, Boersma AW, Liu J, Helmijr J, Ozturk B, Smid M, Wiemer EA, Foekens JA, Martens JW: miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res 2013, 15:R33
24. Guo H, Ingolia NT, Weissman JS, Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840
25. Hognas G, Tuomi S, Veltel S, Mattila E, Murumagi A, Edgren H, Kallioniemi O, Ivaska J: Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo. Oncogene 2012, 31:3597-3606
26. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010, 12:R68
27. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, Kirchner T, Behrens J, Brabletz T: The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008, 68:537-544
28. Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D'Alessio AC, Young RA, Weinberg RA: Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013, 154:61-74
29. Dillner NB, Sanders MM: Transcriptional activation by the zinc-finger homeodomain protein delta EF1 in estrogen signaling cascades. DNA Cell Biol 2004, 23:25-34
30. Sandqvist A, Bjork JK, Akerfelt M, Chitikova Z, Grichine A, Vourc'h C, Jolly C, Salminen TA, Nymalm Y, Sistonen L: Heterotrimerization of heat-shock factors 1 and 2 provides a transcriptional switch in response to distinct stimuli. Mol Biol Cell 2009, 20:1340-1347
31. Wilkerson DC, Skaggs HS, Sarge KD: HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones 2007, 12:283-290
32. Lei R, Tang J, Zhuang X, Deng R, Li G, Yu J, Liang Y, Xiao J, Wang HY, Yang Q, Hu G: Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 2014, 33:1287-1296
33. Liu H, Wang Y, Li X, Zhang YJ, Li J, Zheng YQ, Liu M, Song X, Li XR: Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1. Tumour Biol 2013, 34:1713-1722
34. Chiang CH, Hou MF, Hung WC: Up-regulation of miR-182 by beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta 2013, 1830:3067-3076
35. Hannafon BN, Sebastiani P, de las Morenas A, Lu J, Rosenberg CL: Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res 2011, 13:R24
36. Pellinen T, Arjonen A, Vuoriluoto K, Kallio K, Fransen JA, Ivaska J: Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. J Cell Biol 2006, 173:767-780
37. Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H, Grosse R, Kitzing JK, Kallioniem O, Fassler R, Kallio M, Ivaska J: Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev Cell 2008, 15:371-385
38. Graham TR, Yacoub R, Taliaferro-Smith L, Osunkoya AO, Odero-Marah VA, Liu T, Kimbro KS, Sharma D, O'Regan RM: Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast Cancer Res Treat 2010, 123:139-147
39. miRBase Sequence Database [http://microrna.sanger.ac.uk/]
40. TCGA dataset [http://cancergenome.nih.gov/]
41. ENCODE Project [http://genome.ucsc.edu/ENCODE/]
42. TFSEARCH [http://www.cbrc.jp/research/db/TFSEARCH.html]
43. PicTar [http://pictar.mdc-berlin.de/]
44. TargetScan 5.1 [http://www.targetscan.org]
45. MicroCosm [http://www.ebi.ac.uk/]